AgaMatrix develops and manufactures a line of diabetes products designed to improve the quality of diabetes care. The company's products feature WaveSense, a new technology that personalizes each test to provide world class accuracy. It detects and corrects for many errors caused by differences in blood samples and environmental conditions. Zero-Click, the WaveSense diabetes data management system, was designed to simplify data download. WaveSense and Zero-Click consist of six FDA-cleared products and are protected by a suite of more than 160 patents worldwide.